SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950134-04-012193
Filing Date
2004-08-13
Accepted
2004-08-13 06:01:55
Documents
4
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f01096e10vq.htm 10-Q 215383
2 EXHIBIT 31.1 f01096exv31w1.htm EX-31.1 6782
3 EXHIBIT 31.2 f01096exv31w2.htm EX-31.2 6824
4 EXHIBIT 32.1 f01096exv32w1.htm EX-32.1 5655
  Complete submission text file 0000950134-04-012193.txt   236474
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 04971771
SIC: 2833 Medicinal Chemicals & Botanical Products